Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer.
Kojima T, Shah MA, Muro K, Francois E, Adenis A, Hsu CH, Doi T, Moriwaki T, Kim SB, Lee SH, Bennouna J, Kato K, Shen L, Enzinger P, Qin SK, Ferreira P, Chen J, Girotto G, de la Fouchardiere C, Senellart H, Al-Rajabi R, Lordick F, Wang R, Suryawanshi S, Bhagia P, Kang SP, Metges JP; KEYNOTE-181 Investigators. Kojima T, et al. Among authors: ferreira p. J Clin Oncol. 2020 Dec 10;38(35):4138-4148. doi: 10.1200/JCO.20.01888. Epub 2020 Oct 7. J Clin Oncol. 2020. PMID: 33026938 Clinical Trial.
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
Eggermont AMM, Blank CU, Mandalà M, Long GV, Atkinson VG, Dalle S, Haydon AM, Meshcheryakov A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Di Giacomo AM, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan PC, van Akkooi ACJ, Krepler C, Ibrahim N, Marreaud S, Kicinski M, Suciu S, Robert C; EORTC Melanoma Group. Eggermont AMM, et al. Lancet Oncol. 2021 May;22(5):643-654. doi: 10.1016/S1470-2045(21)00065-6. Epub 2021 Apr 12. Lancet Oncol. 2021. PMID: 33857412 Clinical Trial.
The study of galactomannans with different molecular weights and their ability to form microparticles suitable for pulmonary delivery.
Galrinho MF, Silva LM, Lopes GR, Ferreira BAC, Valente SA, Ferreira I, Pinheiro BA, Palma AS, Evtuguin DV, Lopes da Silva JA, Almeida M, Ferreira P, Cruz MT, Coimbra MA, Passos CP. Galrinho MF, et al. Among authors: ferreira p. Carbohydr Polym. 2024 Sep 1;339:122268. doi: 10.1016/j.carbpol.2024.122268. Epub 2024 May 22. Carbohydr Polym. 2024. PMID: 38823931 Free article.
Mining and engineering activity in catalytic amyloids.
Peña-Díaz S, Ferreira P, Ramos MJ, Otzen DE. Peña-Díaz S, et al. Among authors: ferreira p. Methods Enzymol. 2024;697:345-422. doi: 10.1016/bs.mie.2024.03.002. Epub 2024 Apr 20. Methods Enzymol. 2024. PMID: 38816129
Promising Effects of Casearins in Tumor-Bearing Mice and Antinociceptive Action against Oncologic Pain: Molecular Docking and In Vivo Findings.
Silva JDN, Beserra Filho JIA, Acha BT, Almeida FRC, Batista EKF, Silva VR, Bomfim LM, Soares MBP, Bezerra DP, Dos Santos AG, de Andrade FDCP, Mendes AN, Arcanjo DDR, Ferreira PMP. Silva JDN, et al. Among authors: ferreira pmp. Pharmaceuticals (Basel). 2024 May 14;17(5):633. doi: 10.3390/ph17050633. Pharmaceuticals (Basel). 2024. PMID: 38794204 Free PMC article.
2,360 results